Showing results (221-230 of 828) with videos related to

Sort By:
Pageof 83
BMJ Open Ophthalmology|January 23, 2018
Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stageMayumi Ueta, Hiromi Nishigaki, Chie Sotozono, et al.
BMJ Open Ophthalmology|January 23, 2018
Correlation between baseline retinal microstructures in spectral-domain optic coherence tomography and need for early intervention in central serous chorioretinopathyWei-Yu Lai, Cheui-Lien Tseng, Tsung-Tien Wu, et al.
BMJ Open Ophthalmology|January 23, 2018
Comparative analysis of the visual performance after implantation of the toric implantable collamer lens in stable keratoconus: a 4-year follow-up after sequential procedure (CXL+TICL implantation)Farideh Doroodgar, Feazollah Niazi, Azad Sanginabadi, et al.
BMJ Open Ophthalmology|December 13, 2018
Assessing photoreceptor structure in patients with traumatic head injuryMatthew E Braza, Jonathon Young, Thomas A Hammeke, et al.
BMJ Open Ophthalmology|December 13, 2018
Blindness and eye disease in a Tibetan region of China: findings from a Rapid Assessment of Avoidable Blindness surveyDanba Jiachu, Feng Jiang, Li Luo, et al.
BMJ Open Ophthalmology|May 17, 2021
Factors affecting the corneal endothelium after selective laser trabeculoplasty in primary open angle and angle closure glaucomaNatalia Ivanovna Kurysheva, Lyudmila Vyacheslavovna Lepeshkina, Svetlana Georgievna Kapkova
BMJ Open Ophthalmology|May 13, 2021
Prevalence of keratoconus in persons with Down syndrome: a reviewOlav Kristianslund, Liv Drolsum
BMJ Open Ophthalmology|June 12, 2020
Retinal arteriolar oxygen saturation predicts the need for intravitreal aflibercept in patients with diabetic macular oedemaSøren Leer Blindbæk, Tunde Peto, Jakob Grauslund
BMJ Open Ophthalmology|May 20, 2020
HbA1c as a predictor for response of bevacizumab in diabetic macular oedemaSadhana Sharma, Sagun Narayan Joshi, Pratap Karki
BMJ Open Ophthalmology|May 20, 2020
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapyPaul F Kenna, Marian M Humphries, Anna-Sophia Kiang, et al.
Pageof 83